Avricore Health Inc.
AVCR.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -97.29% | -63.74% | 1.98% | 23.27% | 87.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -97.29% | -63.74% | 1.98% | 23.27% | 87.21% |
| Cost of Revenue | -88.74% | -87.10% | -5.30% | 8.11% | 107.89% |
| Gross Profit | -112.84% | -32.90% | 14.32% | 63.32% | 58.67% |
| SG&A Expenses | 32.77% | 26.82% | 15.50% | 9.44% | -37.70% |
| Depreciation & Amortization | 60.00% | 60.00% | 75.00% | 0.00% | -16.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -51.34% | -50.19% | 1.64% | 8.68% | 20.99% |
| Operating Income | -727.55% | -135.53% | 7.61% | 43.06% | 128.77% |
| Income Before Tax | -940.00% | -143.12% | -1,262.10% | 38.21% | 118.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -940.00% | -143.12% | -1,262.10% | 38.21% | 118.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -940.00% | -143.12% | -1,262.10% | 38.21% | 118.67% |
| EBIT | -727.55% | -135.53% | 7.61% | 43.06% | 128.77% |
| EBITDA | -321.27% | -109.27% | -5.69% | 71.70% | 216.90% |
| EPS Basic | -925.00% | -138.46% | -1,350.00% | 38.10% | 119.05% |
| Normalized Basic EPS | -1,100.00% | -142.86% | 33.33% | 38.46% | 115.38% |
| EPS Diluted | -925.00% | -138.46% | -- | 38.10% | 119.05% |
| Normalized Diluted EPS | -1,100.00% | -142.86% | 33.33% | 38.46% | 115.38% |
| Average Basic Shares Outstanding | 1.42% | 1.55% | 1.58% | 0.76% | 0.24% |
| Average Diluted Shares Outstanding | -4.09% | 1.55% | 1.58% | 0.76% | 6.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |